Cite
HARVARD Citation
Chabria, S. et al. (n.d.). 834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial. Open forum infectious diseases. p. S509. [Online].